- CospiAQ M 25/1000 mg Tablet effectively lowers blood sugar levels in individuals with type 2 diabetes.
- This formulation combines Empagliflozin and Metformin for enhanced glycemic control.
- CospiAQ M 25/1000 mg Tablet reduces the risk of cardiovascular events associated with diabetes.
- It aids in weight management by promoting glucose excretion through urine.
- Patients using CospiAQ M 25/1000 mg Tablet may experience improved insulin sensitivity.
- This medication helps prevent complications related to high blood sugar levels.
- CospiAQ M 25/1000 mg Tablet is suitable for patients who have not achieved adequate control with Metformin alone.
- It supports overall metabolic health and well-being in diabetic patients.
- CospiAQ M 25/1000 mg Tablet can be used alongside lifestyle modifications such as diet and exercise.
- This therapy is beneficial for patients at risk of developing diabetes-related complications.
- CospiAQ M 25/1000 mg Tablet helps in managing polyuria and other symptoms associated with high blood sugar.
- Regular use of CospiAQ M 25/1000 mg Tablet can lead to better long-term health outcomes for diabetic patients.
CospiAQ M 25/1000 mg Tablet - Strip of 10
Prescription Required
Compositions : Empagliflozin 25mg + Metformin 1000mg
₹139.92
(Incl. GST)
MRP :
(Incl. GST)
MRP :
Out of stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Torrent Pharmaceuticals Ltd
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
CospiAQ M 25/1000 mg Tablet is a specialized pharmaceutical formulation designed to manage blood glucose levels effectively. This medication combines two active ingredients, Empagliflozin and Metformin, which work synergistically to provide optimal therapeutic benefits for individuals with type 2 diabetes. The key composition of CospiAQ M 25/1000 mg Tablet includes 25 mg of Empagliflozin and 1000 mg of Metformin, making it a potent option in the antidiabetic category. The primary purpose of CospiAQ M 25/1000 mg Tablet is to lower blood sugar levels while also offering cardiovascular protection, thus addressing multiple aspects of diabetes management. By utilizing this combination therapy, patients can achieve better glycemic control compared to using Metformin alone. CospiAQ M 25/1000 mg Tablet is particularly beneficial for those who struggle with high blood sugar levels and are at risk of diabetes-related complications. The formulation not only aids in glucose regulation but also supports overall metabolic health, making it an essential part of a comprehensive diabetes care plan. With its dual-action mechanism, CospiAQ M 25/1000 mg Tablet helps in reducing glucose production in the liver while promoting the excretion of excess glucose through urine. This unique approach ensures that patients can maintain their blood sugar levels within a healthy range, thereby minimizing the risk of long-term complications associated with diabetes. Overall, CospiAQ M 25/1000 mg Tablet stands out as a reliable and effective treatment option for managing type 2 diabetes, enhancing the quality of life for those affected by this chronic condition.
Product Details
Uses & Benefits
How CospiAQ M 25/1000 mg Tablet works
CospiAQ M 25/1000 mg Tablet works through a dual mechanism involving its active ingredients, Empagliflozin and Metformin. These components collaborate to effectively manage blood glucose levels in patients with type 2 diabetes.
CospiAQ M 25/1000 mg Tablet works through a dual mechanism involving its active ingredients, Empagliflozin and Metformin. These components collaborate to effectively manage blood glucose levels in patients with type 2 diabetes.
- Empagliflozin: Promotes the excretion of excess glucose through urine, thereby lowering blood sugar levels.
- Metformin: Reduces glucose production in the liver and enhances insulin sensitivity, facilitating better glucose uptake by cells.
- Together, these actions help maintain optimal blood sugar levels and reduce the risk of complications associated with diabetes.
- CospiAQ M 25/1000 mg Tablet also aids in weight management by decreasing appetite and promoting fat loss.
- The combination therapy is more effective than Metformin alone in controlling blood sugar levels.
How to use CospiAQ M 25/1000 mg Tablet
- CospiAQ M 25/1000 mg Tablet should be taken as prescribed by a healthcare professional.
- The recommended dosage typically involves one tablet taken orally once daily.
- It is advisable to take CospiAQ M 25/1000 mg Tablet with food to minimize gastrointestinal discomfort.
- The frequency of administration should not exceed the prescribed amount to avoid potential side effects.
- Duration of treatment with CospiAQ M 25/1000 mg Tablet will depend on individual patient needs and response to therapy.
- Patients should monitor their blood sugar levels regularly while using this medication.
- Consult a healthcare provider for any adjustments in dosage based on blood sugar readings or side effects.
Lifestyle Advice
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while using CospiAQ M 25/1000 mg Tablet.
- Engage in regular physical activity to enhance the effectiveness of this medication.
- Avoid excessive consumption of sugary foods and beverages that can spike blood sugar levels.
- Stay hydrated by drinking plenty of water throughout the day while on CospiAQ M 25/1000 mg Tablet.
- Monitor blood sugar levels regularly to ensure they remain within target ranges.
Safety Advice
Side Effects
Side Effects
- Common side effects of CospiAQ M 25/1000 mg Tablet include nausea and vomiting.
- Patients may experience urinary tract infections or genital fungal infections while on this medication.
- Flatulence and dyslipidemia are also reported side effects associated with CospiAQ M 25/1000 mg Tablet.
- Serious side effects may include dehydration due to increased urination; patients should stay hydrated.
- Seek medical attention if experiencing symptoms of severe allergic reactions such as rash or difficulty breathing.
- Consult a doctor if side effects persist or worsen over time while using CospiAQ M 25/1000 mg Tablet.
Precautions and Warnings
Precautions & Warnings
- Individuals with a known allergy to Empagliflozin or Metformin should avoid using CospiAQ M 25/1000 mg Tablet.
- This medication is not recommended for patients with severe kidney impairment or liver disease.
- Pregnant or breastfeeding women should consult their healthcare provider before using CospiAQ M 25/1000 mg Tablet.
- Avoid alcohol consumption while taking this medication due to the risk of hypoglycemia.
- Patients should inform their doctor about all medications they are currently taking to avoid potential drug interactions.
- Regular monitoring of kidney function is advised during treatment with CospiAQ M 25/1000 mg Tablet.
FAQs
1. What is CospiAQ M 25/1000 mg Tablet used for?
CospiAQ M 25/1000 mg Tablet is primarily used for managing blood sugar levels in individuals diagnosed with type 2 diabetes.
2. How should I take CospiAQ M 25/1000 mg Tablet?
It is recommended to take CospiAQ M 25/1000 mg Tablet orally once daily with food to minimize gastrointestinal discomfort.
3. Are there any side effects associated with CospiAQ M 25/1000 mg Tablet?
Common side effects include nausea, vomiting, urinary tract infections, and flatulence. Serious side effects may require medical attention.
4. Can I drink alcohol while taking CospiAQ M 25/1000 mg Tablet?
It is advisable to avoid alcohol consumption while taking CospiAQ M 25/1000 mg Tablet due to the risk of hypoglycemia.
5. Who should avoid using CospiAQ M 25/1000 mg Tablet?
Individuals with severe kidney impairment or known allergies to its components should not use CospiAQ M 25/1000 mg Tablet.
6. How does CospiAQ M 25/1000 mg Tablet work?
CospiAQ M 25/1000 mg Tablet combines Empagliflozin and Metformin to lower blood sugar levels by promoting glucose excretion and reducing liver glucose production.
7. What precautions should I take while using CospiAQ M 25/1000 mg Tablet?
Regular monitoring of kidney function and blood sugar levels is essential while using CospiAQ M 25/1000 mg Tablet.
CospiAQ M 25/1000 mg Tablet is primarily used for managing blood sugar levels in individuals diagnosed with type 2 diabetes.
2. How should I take CospiAQ M 25/1000 mg Tablet?
It is recommended to take CospiAQ M 25/1000 mg Tablet orally once daily with food to minimize gastrointestinal discomfort.
3. Are there any side effects associated with CospiAQ M 25/1000 mg Tablet?
Common side effects include nausea, vomiting, urinary tract infections, and flatulence. Serious side effects may require medical attention.
4. Can I drink alcohol while taking CospiAQ M 25/1000 mg Tablet?
It is advisable to avoid alcohol consumption while taking CospiAQ M 25/1000 mg Tablet due to the risk of hypoglycemia.
5. Who should avoid using CospiAQ M 25/1000 mg Tablet?
Individuals with severe kidney impairment or known allergies to its components should not use CospiAQ M 25/1000 mg Tablet.
6. How does CospiAQ M 25/1000 mg Tablet work?
CospiAQ M 25/1000 mg Tablet combines Empagliflozin and Metformin to lower blood sugar levels by promoting glucose excretion and reducing liver glucose production.
7. What precautions should I take while using CospiAQ M 25/1000 mg Tablet?
Regular monitoring of kidney function and blood sugar levels is essential while using CospiAQ M 25/1000 mg Tablet.
Instructions
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
- Store at room temperature protected from moisture and heat.
- Keep out of reach of children.
- Dispose of unused medication as per local requirements; do not flush or throw in household waste.
More Information
| SKU | 431103 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Torrent Pharmaceuticals Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage |
|
| Seller | Kogland Commerce Pvt Ltd (TN) |
CospiAQ M 25/1000 mg Tablet is a specialized pharmaceutical formulation designed to manage blood glucose levels effectively. This medication combines two active ingredients, Empagliflozin and Metformin, which work synergistically to provide optimal therapeutic benefits for individuals with type 2 diabetes. The key composition of CospiAQ M 25/1000 mg Tablet includes 25 mg of Empagliflozin and 1000 mg of Metformin, making it a potent option in the antidiabetic category. The primary purpose of CospiAQ M 25/1000 mg Tablet is to lower blood sugar levels while also offering cardiovascular protection, thus addressing multiple aspects of diabetes management. By utilizing this combination therapy, patients can achieve better glycemic control compared to using Metformin alone. CospiAQ M 25/1000 mg Tablet is particularly beneficial for those who struggle with high blood sugar levels and are at risk of diabetes-related complications. The formulation not only aids in glucose regulation but also supports overall metabolic health, making it an essential part of a comprehensive diabetes care plan. With its dual-action mechanism, CospiAQ M 25/1000 mg Tablet helps in reducing glucose production in the liver while promoting the excretion of excess glucose through urine. This unique approach ensures that patients can maintain their blood sugar levels within a healthy range, thereby minimizing the risk of long-term complications associated with diabetes. Overall, CospiAQ M 25/1000 mg Tablet stands out as a reliable and effective treatment option for managing type 2 diabetes, enhancing the quality of life for those affected by this chronic condition.
Uses & Benefits
- CospiAQ M 25/1000 mg Tablet effectively lowers blood sugar levels in individuals with type 2 diabetes.
- This formulation combines Empagliflozin and Metformin for enhanced glycemic control.
- CospiAQ M 25/1000 mg Tablet reduces the risk of cardiovascular events associated with diabetes.
- It aids in weight management by promoting glucose excretion through urine.
- Patients using CospiAQ M 25/1000 mg Tablet may experience improved insulin sensitivity.
- This medication helps prevent complications related to high blood sugar levels.
- CospiAQ M 25/1000 mg Tablet is suitable for patients who have not achieved adequate control with Metformin alone.
- It supports overall metabolic health and well-being in diabetic patients.
- CospiAQ M 25/1000 mg Tablet can be used alongside lifestyle modifications such as diet and exercise.
- This therapy is beneficial for patients at risk of developing diabetes-related complications.
- CospiAQ M 25/1000 mg Tablet helps in managing polyuria and other symptoms associated with high blood sugar.
- Regular use of CospiAQ M 25/1000 mg Tablet can lead to better long-term health outcomes for diabetic patients.
How CospiAQ M 25/1000 mg Tablet works
CospiAQ M 25/1000 mg Tablet works through a dual mechanism involving its active ingredients, Empagliflozin and Metformin. These components collaborate to effectively manage blood glucose levels in patients with type 2 diabetes.
CospiAQ M 25/1000 mg Tablet works through a dual mechanism involving its active ingredients, Empagliflozin and Metformin. These components collaborate to effectively manage blood glucose levels in patients with type 2 diabetes.
- Empagliflozin: Promotes the excretion of excess glucose through urine, thereby lowering blood sugar levels.
- Metformin: Reduces glucose production in the liver and enhances insulin sensitivity, facilitating better glucose uptake by cells.
- Together, these actions help maintain optimal blood sugar levels and reduce the risk of complications associated with diabetes.
- CospiAQ M 25/1000 mg Tablet also aids in weight management by decreasing appetite and promoting fat loss.
- The combination therapy is more effective than Metformin alone in controlling blood sugar levels.
How to use CospiAQ M 25/1000 mg Tablet
- CospiAQ M 25/1000 mg Tablet should be taken as prescribed by a healthcare professional.
- The recommended dosage typically involves one tablet taken orally once daily.
- It is advisable to take CospiAQ M 25/1000 mg Tablet with food to minimize gastrointestinal discomfort.
- The frequency of administration should not exceed the prescribed amount to avoid potential side effects.
- Duration of treatment with CospiAQ M 25/1000 mg Tablet will depend on individual patient needs and response to therapy.
- Patients should monitor their blood sugar levels regularly while using this medication.
- Consult a healthcare provider for any adjustments in dosage based on blood sugar readings or side effects.
Lifestyle Advice
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while using CospiAQ M 25/1000 mg Tablet.
- Engage in regular physical activity to enhance the effectiveness of this medication.
- Avoid excessive consumption of sugary foods and beverages that can spike blood sugar levels.
- Stay hydrated by drinking plenty of water throughout the day while on CospiAQ M 25/1000 mg Tablet.
- Monitor blood sugar levels regularly to ensure they remain within target ranges.
Side Effects
Side Effects
- Common side effects of CospiAQ M 25/1000 mg Tablet include nausea and vomiting.
- Patients may experience urinary tract infections or genital fungal infections while on this medication.
- Flatulence and dyslipidemia are also reported side effects associated with CospiAQ M 25/1000 mg Tablet.
- Serious side effects may include dehydration due to increased urination; patients should stay hydrated.
- Seek medical attention if experiencing symptoms of severe allergic reactions such as rash or difficulty breathing.
- Consult a doctor if side effects persist or worsen over time while using CospiAQ M 25/1000 mg Tablet.
Precautions and Warnings
Precautions & Warnings
- Individuals with a known allergy to Empagliflozin or Metformin should avoid using CospiAQ M 25/1000 mg Tablet.
- This medication is not recommended for patients with severe kidney impairment or liver disease.
- Pregnant or breastfeeding women should consult their healthcare provider before using CospiAQ M 25/1000 mg Tablet.
- Avoid alcohol consumption while taking this medication due to the risk of hypoglycemia.
- Patients should inform their doctor about all medications they are currently taking to avoid potential drug interactions.
- Regular monitoring of kidney function is advised during treatment with CospiAQ M 25/1000 mg Tablet.
1. What is CospiAQ M 25/1000 mg Tablet used for?
CospiAQ M 25/1000 mg Tablet is primarily used for managing blood sugar levels in individuals diagnosed with type 2 diabetes.
2. How should I take CospiAQ M 25/1000 mg Tablet?
It is recommended to take CospiAQ M 25/1000 mg Tablet orally once daily with food to minimize gastrointestinal discomfort.
3. Are there any side effects associated with CospiAQ M 25/1000 mg Tablet?
Common side effects include nausea, vomiting, urinary tract infections, and flatulence. Serious side effects may require medical attention.
4. Can I drink alcohol while taking CospiAQ M 25/1000 mg Tablet?
It is advisable to avoid alcohol consumption while taking CospiAQ M 25/1000 mg Tablet due to the risk of hypoglycemia.
5. Who should avoid using CospiAQ M 25/1000 mg Tablet?
Individuals with severe kidney impairment or known allergies to its components should not use CospiAQ M 25/1000 mg Tablet.
6. How does CospiAQ M 25/1000 mg Tablet work?
CospiAQ M 25/1000 mg Tablet combines Empagliflozin and Metformin to lower blood sugar levels by promoting glucose excretion and reducing liver glucose production.
7. What precautions should I take while using CospiAQ M 25/1000 mg Tablet?
Regular monitoring of kidney function and blood sugar levels is essential while using CospiAQ M 25/1000 mg Tablet.
CospiAQ M 25/1000 mg Tablet is primarily used for managing blood sugar levels in individuals diagnosed with type 2 diabetes.
2. How should I take CospiAQ M 25/1000 mg Tablet?
It is recommended to take CospiAQ M 25/1000 mg Tablet orally once daily with food to minimize gastrointestinal discomfort.
3. Are there any side effects associated with CospiAQ M 25/1000 mg Tablet?
Common side effects include nausea, vomiting, urinary tract infections, and flatulence. Serious side effects may require medical attention.
4. Can I drink alcohol while taking CospiAQ M 25/1000 mg Tablet?
It is advisable to avoid alcohol consumption while taking CospiAQ M 25/1000 mg Tablet due to the risk of hypoglycemia.
5. Who should avoid using CospiAQ M 25/1000 mg Tablet?
Individuals with severe kidney impairment or known allergies to its components should not use CospiAQ M 25/1000 mg Tablet.
6. How does CospiAQ M 25/1000 mg Tablet work?
CospiAQ M 25/1000 mg Tablet combines Empagliflozin and Metformin to lower blood sugar levels by promoting glucose excretion and reducing liver glucose production.
7. What precautions should I take while using CospiAQ M 25/1000 mg Tablet?
Regular monitoring of kidney function and blood sugar levels is essential while using CospiAQ M 25/1000 mg Tablet.
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
- Store at room temperature protected from moisture and heat.
- Keep out of reach of children.
- Dispose of unused medication as per local requirements; do not flush or throw in household waste.
| SKU | 431103 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Torrent Pharmaceuticals Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage |
|
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account